Carterra and AstraZeneca are collaborating to develop laboratory hardware and [...]

AstraZeneca’s Trixeo has been approved in the EU as a [...]

AstraZeneca is evaluating its oral IRAK4 inhibitor AZD6793 in a [...]

AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

Tagomics has launched a cell-free DNA platform designed to monitor [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

Kairos Pharma has reported positive interim safety results from an [...]

AstraZeneca is presenting a broad package of new clinical and [...]

AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]

The National Institute for Health and Care Excellence (NICE) has [...]